Shaping Schizophrenia Care: Unveiling the Impact of Cognitive Impairment

home / psych-view / shaping-schizophrenia-care-unveiling-the-impact-of-cognitive-impairment

John M. Kane, MD, and Erin Crown, PA-C, CAQ-Psychiatry, have a comprehensive discussion on cognitive impairment as an emerging therapeutic target in individuals with schizophrenia and how the evolving treatment landscape can fulfill current unmet therapeutic needs.

© 2024 MJH Life Sciences

All rights reserved.